These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 8523870)

  • 1. Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection?
    Menasché P; Kevelaitis E; Mouas C; Grousset C; Piwnica A; Bloch G
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1606-13; discussion 1613-4. PubMed ID: 8523870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is potassium channel opening an effective form of preconditioning before cardioplegia?
    Menasché P; Mouas C; Grousset C
    Ann Thorac Surg; 1996 Jun; 61(6):1764-8. PubMed ID: 8651781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na/H exchange inhibition: which is the best protective strategy for heart transplants?
    Kevelaitis E; Oubénaissa A; Mouas C; Peynet J; Menasché P
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):155-62. PubMed ID: 11135172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of nicorandil as an additive to the solution for continuous warm cardioplegia.
    Qiu Y; Galiñanes M; Hearse DJ
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1063-72. PubMed ID: 7475135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia.
    Sugimoto S; Puddu PE; Monti F; Schiariti M; Campa PP; Marino B
    J Thorac Cardiovasc Surg; 1994 Sep; 108(3):455-66. PubMed ID: 8078338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.
    Grover GJ; Dzwonczyk S; Sleph PG; Sargent CA
    J Pharmacol Exp Ther; 1993 May; 265(2):559-64. PubMed ID: 8496806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nicorandil preconditioning on membrane dystrophin.
    Shojima T; Hayashida N; Nishi A; Takagi K; Hori H; Yoshikawa K; Aoyagi S
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):472-9. PubMed ID: 16859916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels.
    Auchampach JA; Cavero I; Gross GJ
    J Cardiovasc Pharmacol; 1992; 20(5):765-71. PubMed ID: 1280739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants.
    Kevelaitis E; Oubénaïssa A; Peynet J; Mouas C; Menasché P
    Circulation; 1999 Nov; 100(19 Suppl):II345-50. PubMed ID: 10567327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperpolarized cardioplegic arrest with nicorandil: advantages over other potassium channel openers.
    Jayawant AM; Lawton JS; Hsia PW; Damiano RJ
    Circulation; 1997 Nov; 96(9 Suppl):II-240-6. PubMed ID: 9386105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts.
    Mitani A; Kinoshita K; Fukamachi K; Sakamoto M; Kurisu K; Tsuruhara Y; Fukumura F; Nakashima A; Tokunaga K
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1864-71. PubMed ID: 1836311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of myocardial stunning is decreased concentration-dependently by KATP channel activation with nicorandil before high K+ cardioplegia.
    Sugimoto S; Iwashiro K; Monti F; Dawodu AA; Schiariti M; Puddu PE
    Int J Cardiol; 1995 Jan; 48(1):11-25. PubMed ID: 7744533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicorandil, a potent adenosine triphosphate-sensitive potassium-channel opener, ameliorates lung allograft reperfusion injury.
    Yamashita M; Schmid RA; Fujino S; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1307-14. PubMed ID: 8911328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection?
    Cohen NM; Wise RM; Wechsler AS; Damiano RJ
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):317-28. PubMed ID: 7848379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest.
    Ogino H; Smolenski RT; Zych M; Seymour AM; Yacoub MH
    Ann Thorac Surg; 1996 Aug; 62(2):469-74. PubMed ID: 8694607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart.
    Lawton JS; Harrington GC; Allen CT; Hsia PW; Damiano RJ
    Ann Thorac Surg; 1996 Jun; 61(6):1680-8. PubMed ID: 8651767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
    Zhu B; Min S; Long C; Ye T
    Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium.
    Pomerantz BJ; Robinson TN; Morrell TD; Heimbach JK; Banerjee A; Harken AH
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):387-92. PubMed ID: 10917958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A; Hellegouarch A
    J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.